Ekso Bionics® (EKSO) is a worldwide pioneer in the field of robotic exoskeletons. For over 10 years they have been committed to developing the latest technology and engineering to help people rethink current physical limitations and achieve the remarkable.
Ekso Bionics products unlock human strength, endurance, and mobility potential, with broad applications across medical and industrial markets. One of their products is the robotic exoskeleton. This is a ready to wear, battery-powered robot that is strapped over the users’ clothing, enabling individuals to achieve mobility, strength, or endurance not otherwise possible. In 2016, Ekso Bionics received the first FDA clearance exoskeleton for use with stroke and spinal cord injury levels to C7.
Vodafone IoT will be connecting the world’s first exoskeleton that is FDA cleared for use with both stroke patients and spinal cord injuries, the Ekso GT™. Vodafone’s IoT managed connectivity service will ensure reliable communication globally for diagnostics and improved access to patient data, helping to improve the user experience with the suit.
The Ekso GT can provide adaptive amounts of power to either side of the patient’s body, helping to improve results for patients. The suit allows physical therapists to mobilise patients earlier, more frequently and with a greater number of high intensity steps, all of which will aid recovery.
With Vodafone IoT technology, exoskeletons are performing in real time, providing therapists with data on how the patients’ rehabilitation is progressing.
Vodafone’s managed connectivity service means Ekso Bionics can expand globally easily, cost effectively and without dealing with multiple suppliers.
“What we have found with Vodafone is truly a partnership. We’re working closely with them not only on the current products but on the future products.”